Exogenous peptides compete for the presentation of endogenous antigens to major histocompatibility complex class II-restricted T cells.
about
Presentation of newly synthesized glycoproteins to CD4+ T lymphocytes. An analysis using influenza hemagglutinin transport mutants.Endogenous antigen presentation by autoantigen-transfected Epstein-Barr virus-lymphoblastoid cells. I. Generation of human thyroid peroxidase-reactive T cells and their T cell receptor repertoireInduction of dominant transplantation tolerance by an altered peptide ligand of the male antigen Dby.Peptide-induced T-cell tolerance to prevent autoimmune diabetes in a transgenic mouse model.Peptide-major histocompatibility complex class II complexes with mixed agonist/antagonist properties provide evidence for ligand-related differences in T cell receptor-dependent intracellular signalingMajor histocompatibility complex class II-restricted presentation of an internally synthesized antigen displays cell-type variability and segregates from the exogenous class II and endogenous class I presentation pathwaysIdentification of the cellular sentinels for native immunogenic heat shock proteins in vivo.Hoxb8 conditionally immortalised macrophage lines model inflammatory monocytic cells with important similarity to dendritic cells.CD4(+) T cells induced by a DNA vaccine: immunological consequences of epitope-specific lysosomal targeting.New approaches to specific immunomodulation in transplantation.Self-peptide released from class II HLA-DR1 exhibits a hydrophobic two-residue contact motif.Epitope-specific enhancement of antigen presentation by invariant chain.Selective immunosuppression by administration of major histocompatibility complex (MHC) class II-binding peptides. I. Evidence for in vivo MHC blockade preventing T cell activation.HgCl2-induced interleukin-4 gene expression in T cells involves a protein kinase C-dependent calcium influx through L-type calcium channels.The Major Histocompatibility Complex
P2860
Q30466290-93347AC4-DB11-4175-BB5C-776C578480B9Q33895998-710DA651-90E4-4807-8749-CA1DF7E59115Q34380578-D0BC33EC-DFA2-4982-A69F-AF099F429F50Q34975904-F2917777-0F92-48C1-A8D6-BFBF3B7F7496Q36361605-4B7F7598-DCC2-4183-A83E-7CBBE2A6B744Q36361976-F33B88FA-636F-4D15-BC01-BC12D3652BB5Q37240798-51C913B4-BC72-4B5A-808B-6AD782534A02Q39602540-B575F46D-1AD3-49B2-BB2D-1A71E6AF6FFCQ39604745-AF1EEEF2-1BDC-48D9-90D7-6D69F3A445C3Q41091885-038A7362-0CB3-4721-964B-9239B264D08DQ41622259-BEAD9EA0-72A8-4453-8BBB-95AA2A610E3AQ41937027-902F9CFF-8DB7-4D29-9115-64C7DB3524A1Q41940214-649E04B2-79EB-4C0F-A513-A745DA6BD5C7Q42545982-731C0933-5B50-46FF-8C86-03AC42F91C32Q57159149-FE6D95C0-00FE-468A-8E2C-32B574A5F666
P2860
Exogenous peptides compete for the presentation of endogenous antigens to major histocompatibility complex class II-restricted T cells.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Exogenous peptides compete for ...... x class II-restricted T cells.
@en
type
label
Exogenous peptides compete for ...... x class II-restricted T cells.
@en
prefLabel
Exogenous peptides compete for ...... x class II-restricted T cells.
@en
P2093
P2860
P356
P1476
Exogenous peptides compete for ...... ex class II-restricted T cells
@en
P2093
P2860
P304
P356
10.1084/JEM.174.4.945
P407
P577
1991-10-01T00:00:00Z